文献速递冠心病外科

胸廓内动脉是否抵抗再灌注损伤?游离胸廓内动脉移植物保存的评估

Is internal thoracic artery resistant to reperfusion injury? Evaluation of the storage of free internal thoracic artery grafts.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-06-08

研究在猪模型中比较游离与在位胸廓内动脉(ITA)移植后的内皮功能,游离ITA分别保存于生理盐水、Custodiol和Tiprotec溶液。再灌注2小时后,游离ITA组内皮功能与完整性严重受损,Tiprotec组部分保留;在位ITA未见损伤迹象。作者认为Tiprotec可能是冠状动脉旁路移植术中游离动脉移植物保存的可行选择。

要点

  • 游离ITA再灌注后内皮功能与完整性严重受损,在位ITA未见损伤迹象。
  • Tiprotec保存的游离ITA内皮功能部分保留。
  • 游离ITA组再灌注后硝化氧化应激、DNA断裂及血管细胞黏附蛋白1等评分升高,内皮型一氧化氮合酶评分降低。

核心结论

  • 游离ITA保存后再灌注可导致早期严重内皮功能障碍,而在位ITA移植可完全预防此种损伤。
  • Tiprotec可能是冠状动脉旁路移植术中游离动脉移植物保存的可行选择。

研究设计与样本

  • 猪模型实验,ITA分别作为游离或在位移植物获取,游离移植物保存于生理盐水、Custodiol和Tiprotec溶液,非体外循环吻合至左前降支,再灌注2小时后获取移植物评估内皮功能、组织病理学和基因表达,新鲜获取的ITA作为对照。

主要发现

  • 再灌注后游离ITA组内皮功能与完整性严重受损,Tiprotec组部分保留。
  • 游离ITA组再灌注损伤导致硝化氧化应激、DNA断裂、血管细胞黏附蛋白1、细胞间黏附分子-1和caspase-3评分升高,内皮型一氧化氮合酶评分降低。
  • 在位ITA移植物未见损伤迹象。
  • 各组间mRNA水平显著改变。

临床怎么用

  • 作者认为Tiprotec可能是冠状动脉旁路移植术中游离动脉移植物保存的可行选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The in situ internal thoracic artery (ITA) is recognized as the best conduit for coronary artery bypass surgery. The ITA-if it is used as an in situ graft-has a much higher late patency rate than any other arterial graft, including a free ITA graft. We sought to determine if the use of the ITA as an in situ/free graft and its storage in preservation solutions, have an effect on endothelial function. METHODS: The ITA was harvested as either a free or in situ graft in a porcine model. Free grafts were stored in different preservation solutions (saline, Custodiol and Tiprotec [both Köhler Chemie GmbH, Bensheim, Germany]). The ITA was anastomosed off pump to the left anterior descending artery (as in situ/free graft). Freshly harvested ITA served as a control. After 2 hours of reperfusion, the implanted grafts were harvested. The assessment of endothelial function, histopathological analysis, and gene expression were performed. RESULTS: Endothelial function and integrity were severely impaired after reperfusion in the free ITA groups, however, it was partially preserved in the Tiprotec group. Reperfusion injury resulted in increased nitro-oxidative stress, DNA breakage, vascular cell adhesion protein 1, intercellular adhesion molecule-1, and caspase-3 scores, and a decreased endothelial nitric oxide synthase score in the free ITA groups. The in situ ITA graft showed no signs of injury. mRNA levels were significantly altered among the groups. CONCLUSIONS: An early, severe endothelial dysfunction of the stored, free ITA as described, could be completely prevented by the use of an in situ ITA graft. Tiprotec might be a feasible option for storage of free arterial grafts during coronary artery bypass grafting.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Veres G, Schmidt H, Hegedűs P, et al. Is internal thoracic artery resistant to reperfusion injury? Evaluation of the storage of free internal thoracic artery grafts. J Thorac Cardiovasc Surg. 2018. PMID: 30257283. doi:10.1016/j.jtcvs.2018.05.079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。